However, our previous studies using recombinant modified LCAT(C31Y) proteins in rabbits have provided proof-of-concept evidence that LCAT activation facilitates cholesterol mobilization, promotes RCT in vivo, and attenuates atherogenesis under high fat diet-induced hypercholesterolemia (28). This evidence concerns the gene LCAT and Hypercholesterolemia.